Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma.

Scientific reports - 9 Jul 2024

Hwang Jia, Lee Hye Eun, Han Jin Seon, Choi Moon Hyung, Hong Sung Hoo, Kim Sae Woong, Yang Ji Hoon, Park Unsang, Jung Eun Sun, Choi Yeong Jin

Abstract excerpt

Although sex differences have been reported in patients with clear cell renal cell carcinoma (ccRCC), biological sex has not received clinical attention and genetic differences between sexes are poorly understood. This study aims to identify sex-specific gene mutations and explore their clinical significance in ccRCC. We used data from The Cancer Genome Atlas-Kidney Renal Clear Cell Carcinoma (TCGA-KIRC), The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Renal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Histone Demethylases

Share to Kidney Neoplasms

Share to Sex Factors

Share to Tumor Suppressor Proteins

Share to Ubiquitin Thiolesterase

Source

Open in PubMed Open full text

Identifiers

PMID: 38982123
DOI: 10.1038/s41598-024-66525-9
PMCID: PMC11233666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma.PMID 38982123Read ↗

Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC).Semantic proximity Read ↗

Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.Semantic proximity Read ↗

Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma.Semantic proximity Read ↗

Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencingSemantic proximity Read ↗

[Clinicopathological features of BAP1 mutated clear cell renal cell carcinoma].Semantic proximity Read ↗

Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinomaSemantic proximity Read ↗

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network.Semantic proximity Read ↗

Sex specific associations in genome wide association analysis of renal cell carcinomaSemantic proximity Read ↗

Olfactory Receptor Expression Profiles in Clear Cell Renal Cell Carcinoma Reveal Potential Diagnostic and Prognostic MarkersSemantic proximity Read ↗

A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1Semantic proximity Read ↗

Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.Semantic proximity Read ↗

Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.